EUVIMEDEUVIMED entdecken
Crossref

Statins and Hospitalizations from Recurrent Falls in the Elderly

Zvi Shimoni, Erika Eva Kalaora, Vered Hermush, Paul Froom

Gerontology · 2025

DOI: 10.1159/000548176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, 2025. Verfasst von Zvi Shimoni und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Adelson School of Medicine, Ariel University, Ari'el, Israel. Hauptthemen laut MEDLINE: Accidental Falls, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hospitalization. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Statin-induced myopathy might increase the risk of falls in the elderly and change treatment decisions.

Methods

In the following retrospective study, we selected 463 internal medicine patients aged ≥70 years old hospitalized after a fall during 2020–2021. We compared those with and without an admission for a previous fall in the last 12 months. The primary predictors were polypharmacy (≥5 drugs or ≥9 drugs), antidiabetic drugs, psychiatric drugs, drugs for hypertension, and statins (types and dose). Secondary predictors included age, female gender, admission serum creatinine, albumin, and hemoglobin concentrations, smoking at present, the Norton scale, and if the statin was given for primary prevention (no cardiovascular diseases), the patient’s ambulatory status, where and when the patient fell, and what the patient was doing when the fall took place. We calculated the odds ratios and 95% confidence intervals for associations with recurrent versus single falls.

Results

There were 463 patients hospitalized after a fall. Their age was 84 ± 7 years, and 47.7% (221/463) were female. There were 19.0% (88/463) who had recurrent falls, 116 patients treated with atorvastatin (25.1%) and 98 treated with other statins (21.2%). The secondary variables were not significantly different in those with and without recurrent falls. There was a significant increase in odds for recurrent falls in those treated with atorvastatin (1.68, 1.01–2.81) and insulin (2.46, 1.23–4.95). Individually, the drugs were not associated with recurrent falls, but the combination of both drugs was associated with a 5.2 (2.1–13.2) increased odds of a recurrent fall.

Conclusions

The finding that the combined treatment with atorvastatin and insulin is associated with recurrent falls in elderly hospitalized patients is novel and warrants further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Accidental FallsHydroxymethylglutaryl-CoA Reductase InhibitorsHospitalizationHumansFemaleMaleAgedAged, 80 and overRetrospective StudiesPolypharmacyRecurrenceRisk FactorsAtorvastatin

Stichwörter der Autor:innen

ElderlyRecurrent fallsStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAtorvastatin

Autor:innen und Institutionen

  • The Adelson School of Medicine, Ariel University, Ari'el, Israel.
  • Clinical Utility Department, Sanz Medical Center And School of Public Health, University of Tel Aviv, Tel Aviv, Israel.
  • Dorot, Geriatric Center, Israel Ministry of Health, Jerusalem, Israel.
  • Department of Geriatrics, Sanz Medical Center, Laniado Hospital, Netanya, Israel.

Zitieren

APA

Shimoni, Z., Kalaora, E. E., Hermush, V., & Froom, P. (2025). Statins and Hospitalizations from Recurrent Falls in the Elderly. Gerontology. https://doi.org/10.1159/000548176

Vancouver

Shimoni Z, Kalaora EE, Hermush V, Froom P. Statins and Hospitalizations from Recurrent Falls in the Elderly. Gerontology. 2025. doi:10.1159/000548176

BibTeX
@article{Shimoni2025,
  author = {Shimoni, Zvi and Kalaora, Erika Eva and Hermush, Vered and Froom, Paul},
  title = {Statins and Hospitalizations from Recurrent Falls in the Elderly},
  journal = {Gerontology},
  year = {2025},
  doi = {10.1159/000548176}
}
Kostenlos starten →